Plasma glycomics predict cardiovascular disease in patients with ART-controlled HIV infections.
Oswald DM, Sim ES, Baker C, Farhan O, Debanne SM, Morris NJ, Rodriguez BG, Jones MB, Cobb BA.
Oswald DM, et al. Among authors: baker c.
FASEB J. 2019 Feb;33(2):1852-1859. doi: 10.1096/fj.201800923R. Epub 2018 Sep 5.
FASEB J. 2019.
PMID: 30183373
Free PMC article.
Our findings constitute the discovery of novel glycan biomarkers that could classify patients with HIV with elevated risk for CVD and reveal the untapped prognostic potential of the plasma glycome in human disease.-Oswald, D. M., Sim, E. S., Baker, C., Farhan, O., D …
Our findings constitute the discovery of novel glycan biomarkers that could classify patients with HIV with elevated risk for CVD and reveal …